Skip to content
Subscriber Only

Glaxo Case Pushes U.S. Health Settlements to $6.6 Billion

GlaxoSmithKline Plc, Johnson & Johnson and other drugmakers have paid $6.6 billion this year to settle claims of defrauding U.S. health programs, more than double the amount of 2011, advocacy group Public Citizen said.

Fines and penalties rose from $2.5 billion in 2011, aided by a record $3 billion settlement by Glaxo in July, Washington-based Public Citizen said in a report today. Common frauds include overcharging government programs such as Medicare and pushing doctors to prescribe drugs for unapproved uses.